Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 19 January 2010
Vol. 3, Issue 105, p. pe3
[DOI: 10.1126/scisignal.3105pe3]

PERSPECTIVES

TAK-ling IKK Activation: "Ub" the Judge

Shelly M. Wuerzberger-Davis and Shigeki Miyamoto*

Department of Pharmacology, University of Wisconsin-Madison, 6159 Wisconsin Institute for Medical Research, 1111 Highland Avenue, Madison, WI 53705, USA.

Abstract: Investigation of the signaling events that lead to the activation of the transcription factor nuclear factor {kappa}B (NF-{kappa}B) has been a hotbed for the discovery of previously uncharacterized signaling mechanisms. The important role that nondegradative polyubiquitin chains play in these processes is now well recognized; however, precisely how they orchestrate NF-{kappa}B signaling is still a matter of much controversy. A recent study has challenged the dogmatic view by demonstrating that interleukin-1β (IL-1β), a major proinflammatory cytokine, activates two consecutive pathways, the "RING" and "zinc" pathways, to coordinate early and late activation of NF-{kappa}B, respectively. This study introduces a paradigm shift in the still-evolving mechanism of regulation of NF-{kappa}B.

* Corresponding author. E-mail, smiyamot{at}wisc.edu

Citation: S. M. Wuerzberger-Davis, S. Miyamoto, TAK-ling IKK Activation: "Ub" the Judge. Sci. Signal. 3, pe3 (2010).

Read the Full Text



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882